0383 Search Results


arecaidine propargyl ester tosylate  (Tocris)
92
Tocris arecaidine propargyl ester tosylate
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
Arecaidine Propargyl Ester Tosylate, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/Arecaidine+propargyl+ester+tosylate/pmc09710075-18-9-17
Average 92 stars, based on 1 article reviews
arecaidine propargyl ester tosylate - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
o benzotriazole n  (Chem Impex International)
95
Chem Impex International o benzotriazole n
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
O Benzotriazole N, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/O-(Benzotriazol-1-yl)-N%2CN%2CN'%2CN'-tetramethyluronium+tetrafluoroborate/pm36316409-323-25-29
Average 95 stars, based on 1 article reviews
o benzotriazole n - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
biotinylated h3k27cr  (EpiCypher)
92
EpiCypher biotinylated h3k27cr
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
Biotinylated H3k27cr, supplied by EpiCypher, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/Nucleosome%2C+Recombinant+Human%2C+H3K27cr+dNuc%2C+Biotinylated/pmc11046469__oc3c01419_si_001-107-12-16
Average 92 stars, based on 1 article reviews
biotinylated h3k27cr - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
origin® v7.0383  (OriginLab corp)
90
OriginLab corp origin® v7.0383
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
Origin® V7.0383, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/program+origin+v7+0383/us09040668-169-5-7
Average 90 stars, based on 1 article reviews
origin® v7.0383 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
origin v.7.0383  (OriginLab corp)
90
OriginLab corp origin v.7.0383
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
Origin V.7.0383, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/origin+v++7+0383/pmc08897410-305-23-25
Average 90 stars, based on 1 article reviews
origin v.7.0383 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
origin v 7.0383 software  (OriginLab corp)
90
OriginLab corp origin v 7.0383 software
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
Origin V 7.0383 Software, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/origin+v+7+0383+software/pmc01839166-296-8-12
Average 90 stars, based on 1 article reviews
origin v 7.0383 software - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
originpro v. 7.0383  (OriginLab corp)
90
OriginLab corp originpro v. 7.0383
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
Originpro V. 7.0383, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/originpro+v++7+0383/pmc02748857-55-12-15
Average 90 stars, based on 1 article reviews
originpro v. 7.0383 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
hepaticult organoid differentiation media 100–0383  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc hepaticult organoid differentiation media 100–0383
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
Hepaticult Organoid Differentiation Media 100–0383, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/hepaticult+organoid+differentiation+media+100+0383/pm40670531-158-0-4
Average 90 stars, based on 1 article reviews
hepaticult organoid differentiation media 100–0383 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
adenovector adef.11d 1.0383 pu/ml×10 12  (Genvec Inc)
90
Genvec Inc adenovector adef.11d 1.0383 pu/ml×10 12
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
Adenovector Adef.11d 1.0383 Pu/Ml×10 12, supplied by Genvec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/adenovector+adef+11d+1+0383+pu+ml%C3%9710+12/pmc03300073-85-1-20
Average 90 stars, based on 1 article reviews
adenovector adef.11d 1.0383 pu/ml×10 12 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
origin version 7.0383  (OriginLab corp)
90
OriginLab corp origin version 7.0383
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
Origin Version 7.0383, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/origin+version+7+0383/pmc06608359-160-5-8
Average 90 stars, based on 1 article reviews
origin version 7.0383 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
origin 7 sr2 software, version 7.0383  (OriginLab corp)
90
OriginLab corp origin 7 sr2 software, version 7.0383
Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, <t>arecaidine</t> propargyl ester <t>tosylate,</t> VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM
Origin 7 Sr2 Software, Version 7.0383, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/0383/origin+7+sr2+software++version+7+0383/10__3390_slash_catal3010324-338-0-6
Average 90 stars, based on 1 article reviews
origin 7 sr2 software, version 7.0383 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, arecaidine propargyl ester tosylate, VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM

Journal: Molecular Brain

Article Title: Involvement of muscarinic receptors in psychomotor hyperactivity in dopamine-deficient mice

doi: 10.1186/s13041-022-00984-x

Figure Lengend Snippet: Effects of CHRM subtype-selective agonists and antagonists on CHRM density and locomotor activity in DD mice. ( a – c ) Binding assays with [ 3 H]pirenzepine, [ 3 H]AFDX-384, and [ 3 H]4-DAMP were conducted. WT mice: n = 5, DD mice: n = 5. ** p < 0.01 (Student’s t -test). The data are expressed as the mean + SEM with data point overlap. ( d - h ) Change in locomotor activity in WT mice ( n = 11–12) and DD mice ( n = 9–12) following xanomeline, arecaidine propargyl ester tosylate, VU0255035, AQRA-741, and saline treatment. * p < 0.05, ** p < 0.01 (two-way repeated-measures ANOVA). The data are expressed as the mean ± SEM

Article Snippet: Xanomeline (CHRM1/CHRM4 agonist; 10 mg/kg; Tocris Bioscience, Bristol, UK), arecaidine propargyl ester tosylate (CHRM2 agonist; 5 mg/kg; Tocris Bioscience), VU0255035 (CHRM1 antagonist; 10 mg/kg; Tocris Bioscience), and AQRA-741 (CHRM2 antagonist; 1 mg/kg; Tocris Bioscience) were dissolved in saline and administered subcutaneously.

Techniques: Activity Assay, Binding Assay, Saline